Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions

Immune checkpoint inhibitors (ICPIs) targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) pathways have transformed systemic therapy for advanced hepatocellular carcinoma (HCC), prompting exploration of their...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Maen Abdelrahim, Abdullah Esmail, Bandar Al-Judaibi, Ola Khorshid, Bhoori Sherrie, Vincenzo Mazzaferro
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2026-05-01
Cyfres:	Frontiers in Oncology
Pynciau:	Hepatocellular carcinoma immune checkpoint inhibitors liver transplantation Milan criteria transplant oncology UCSF criteria
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1826765/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!